Antimicrobial resistance and related issues: An overview of Bangladesh situation


  • Md. Sayedur Rahman Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka
  • Sharmila Huda Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka



Antimicrobial resistance, Bangladesh situation


The present study was designed to understand Bangladesh situation about antimicrobial resistance. Half of the Escherichia coli, Staphylococcus aureus, Pseudomonas and Klebsiella showed resistance against older and common antimicrobials. Most (50%) common reasons to prescribe antimicrobial are fever, respiratory and urinary tract infection. About 70% prescriber mentioned diagnostic uncertainty and emergence of resistance as causes for increase in antimicrobial prescribing. 51.9% of prescribers opined that physicians prescribe antimicrobial more than the actual need. About two-third of 5th year medical students answered correctly on different issues related to antimicrobials and resistance. Antimicrobial and resistance received little emphasis in Pharmacology and Microbiology written questions at both undergraduate (0.7 to 16.1%) and postgraduate (0.9 to 18.4%) level. Print (0.02% to 2.0%) and electronic media (0.0 to 0.6%) attaches small importance on the issues. Nothing related to antimicrobials and measure to contain resistance were mentioned in related policy documents.


Download data is not yet available.
4061 Read

Author Biography

Md. Sayedur Rahman, Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka



Akond MA, Alam S, Hassan SMR, Shirin M. Antibiotic resistance of Escherichia Coli isolated from poultry and poultry environment of Bangladesh. Int J Food Safety 2009; 11: 19-23.

Bangladesh Medical & Dental Council (BMDC). Curriculum for Undergraduate Medical Education in Bangladesh: Updated 2012. Dhaka 1000, Bangladesh, 2012, pp 1-393. Available at

Begum M, Rahman MS, Islam AFMS, Khan IA, Akhter N. Eleven years of the undergraduate medical curriculum 1988: Review on the changes in Pharmacology written questions. Bangladesh J Physiol Pharmacol. 1999; 15: 27-30.

Chowdhury AK, Rahman MS, Faroque AB, Hasan GA, Raihan SZ. Excessive use of avoidable therapeutic injections in the Upazilla health complexes of Bangladesh. Mymensingh Med J. 2008; 17(2 Suppl): S59-64.

Das AK, Rahman MS. Prescribing vitamins at primary health care level: Exploration of facts, factors and solution. Bangladesh J Pharmacol. 2010; 5: 92-97.

Faiz MA, Basher A. Antimicrobial resistance: Bangladesh experience. Regional Health Forum 2011; 15: 1-8.

Faiz MA, Rahman MR. Rational antimicrobial use. J CMCTA 2004; 15: 1-3.

Hasan B, Nahar SG, Akter L, Saleh A. Antimicrobial sensitivity pattern of Salmonella typhi isolated from blood culture in a referral hospital. Bangladesh J Med Microbiol. 2011; 05: 16-20.

Holloway KA. Bangladesh: Pharmaceuticals in health care delivery. Mission Report. New Delhi, World Health Organization, Regional Office for South East Asia, 2010, pp 17-24.

Islam MS, Rahman MS, Misbahuddin M. Impact of ‘Prescription Audit & Feedback’ on pattern of prophylactic antimicrobials in caesarean section: A cost reduction perspective. Bangladesh J Physiol Pharmacol. 2007; 23: 1-9.

Jackson JH. Clemenceau and the third Republic. London, Hodder & Stoughton for the English Universities Press, 1946, p 228.

Levy SB. The antibiotic paradox. 2nd ed. Cambridge, USA, Perseus Publlishing, 2002.

Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999; 5: 18–27.

Okeke IN, Laxminarayan R, Bhutto ZA, Duse AG, Jenkins P, O’Brian TF, Pablos-Mendez A, Klugman KP. Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect Dis. 2005; 5: 481-93.

Rahman M, Shoma S, Rashid H, Arifeen SE, Baqui AH, Siddique AK, Nair GB, Sack DA. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: Resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr. 2007; 25: 158–67.

Rahman MS, Kamal ASMA, Chwodhury S, Khan IA, Islam AMZ, Sultana R, Begum M, Akhter N, Anwar AKMN. Exercise on selection of P-drug: Preliminary evaluation of a newer method of Pharmacotherepy teaching in Bangladesh. Bangladesh J Physiol Pharmacol. 2000; 16: 50-54.

Rahman MS, Khan IA, Chowdhury S, Islam AMZ, Sultana R, Hoque MZ, Akhter N. A baseline survey on the use of drugs at private practitioner level in Bangladesh. Bangladesh J Physiol Pharmacol. 1998; 14: 47-50.

Rahman MS. Changes required in pharmacotherapy teaching to ensure rational use of drugs. Bangladesh J Physiol Pharmacol. 1995; 11: 38-39.

Rahman MS. Health Care Reform, A global phenomenon: Can Bangladesh respond properly? Bangladesh Med J. 1995; 24: 28-30.

Rahman MS. New global situation in drug regulation: Redefined responsibility of the Pharmacologists of Bangladesh. Bangladesh J Physiol Pharmacol. 1999; 15: 41-42.

Rogers BA, Aminzadeh Z, Hayashi Y, Peterson DL. Country-to-Country transfer of patients and the risk of multi-resistant bacterial infections. Clin Infect Dis. 2011; 53: 49-56.

Shnayerson M, Plotkin MJ. The killers within the deadly rise of drug-resistant bacteria. New York, USA, Little Brown & Company, 2002.

World Health Organization (WHO). Fifty first World Health Assembly. WHA 51.17. Agenda item 21.3. Geneva, 1998.

World Health Organization (WHO). Implementation workshop on the WHO global strategy for containment of antimicrobial resistance. Geneva, Department of Communicable Disease Surveillance and Response, 2002.

World Health Organization. Overcoming antimicrobial resis-tance. Geneva, WHO, 2000.



How to Cite

Rahman, M. S., and S. Huda. “Antimicrobial Resistance and Related Issues: An Overview of Bangladesh Situation”. Bangladesh Journal of Pharmacology, vol. 9, no. 2, May 2014, pp. 218-24, doi:10.3329/bjp.v9i2.18831.



Research Articles